Carregant...
Guanfacine Decreases Symptoms of Cannabis Withdrawal in Daily Cannabis Smokers
The α2a-adrenergic agonist, lofexidine, reduced cannabis withdrawal-related sleep disruption in the laboratory, but side effects (e.g., fatigue, hypotension) limit its utility as a treatment for cannabis use disorder (CUD). This study tested the potential efficacy and tolerability of a daily bedtime...
Guardat en:
| Publicat a: | Addict Biol |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6191371/ https://ncbi.nlm.nih.gov/pubmed/29659126 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/adb.12621 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|